You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice

Article info

Article menu

Download PDFPDF

Scientific Abstracts
Publication Only
Scleroderma, myositis and related syndromes
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice

Authors

Citation

Koneva O, Garzanova L, Glukhova S, et al
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice
Annals of the Rheumatic Diseases 2022;81:1491.

Publication history

  • First published May 23, 2022.
Online issue publication 
June 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.